Endocrine responses to ghrelin in adult patients with isolated childhood-onset growth hormone deficiency

被引:18
作者
Aimaretti, G
Baffoni, C
Broglio, F
Janssen, JAM
Corneli, G
Deghenghi, R
van der Lely, AJ
Ghigo, E
Arvat, E
机构
[1] Univ Turin, Inst Internal Med, Div Endocrinol & Metab, I-10126 Turin, Italy
[2] Erasmus Univ, Dept Internal Med, Div Endocrinol, NL-3000 DR Rotterdam, Netherlands
[3] Europeptides, Argenteuil, France
关键词
D O I
10.1046/j.1365-2265.2002.01547.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE Ghrelin, a 28 amino acid acylated peptide, Is a natural ligand of the GH secretagogues (GHS) receptor (GHS-R), which is specific for synthetic GHS. Similar to synthetic GHS, ghrelin strongly stimulates GH secretion but also displays significant stimulatory effects on lactotroph and corticotroph secretion. It has been hypothesized that isolated GH deficiency (GHD) could reflect hypothalamic impairment that would theoretically involve defect in ghrelin activity. PATIENTS In the present study, we verified the effects of ghrelin (1 mug/kg i.v.) on GH, PRL, ACTH and cortisol levels in adult patients with isolated severe GHD [five males and one female, age (mean SEM) 24.7 +/- 2.6 years, BMI 25.7 +/- 2.7 kg/m(2)]. In all patients, the GH response to insulin-induced hypoglycaemia (ITT, 0.1 IU regular insulin i.v.) and GH releasing hormone (GHRH) (1 mug/kg i.v.) + arginine (ARG, 0.5 g/kg i.v.) was also studied. The hormonal responses in GHD were compared with those in age-matched normal subjects (NS, seven males, age 28.6 +/- 2.9 years, BMI 22.1 +/- 0.8 kg/m(2)). RESULTS IGF-I levels in GHD were markedly lower than in NS (69.8 +/- 11.3 vs. 167.9 +/- 19.2 mug/l, P < 0.003). Ghrelin administration induced significant increase in GH, PRL, ACTH and cortisol levels in all GHD. In GHD, the GH response to ghrelin was higher (P < 0.05) than that to GHRH + ARG, which, in turn, was higher (P < 0.05) than that to ITT (9.2 +/- 4.1 vs. 5.3 +/- 1.7 vs. 1.4 +/- 0.4 mu g/l). These GH (1 mu g/l = 2 mU/l) responses in GHD were markedly lower (P < 0.0001) than those in NS (ghrelin vs. GHRH + ARG vs. ITT 92.1 +/- 16.7 vs. 65.3 +/- 8.9 vs. 17.7 +/- 3.5 mug/l). In GHD, the highest individual peak GH response to ghrelin was markedly lower than the lowest peak GH response in NS (28.5 vs. 42.9 mug/l). GHD and NS showed overlapping PRL (1 mug/l = 32 mU/l) (10.0 +/- 1.4 vs. 14.9 +/- 2.2 mug/l), ACTH (22.3 +/- 5.3 vs. 18.7 +/- 4.6 pmol/l) and cortisol responses (598.1 +/- 52.4 vs. 486.9 +/- 38.9 nmol/l). CONCLUSIONS This study shows that ghrelin is one of the most powerful provocative stimuli of GH secretion, even in those patients with isolated severe GHD. In this condition, however, the somatotroph response is markedly reduced while the lactotroph and corticotroph responsiveness to ghrelin is fully preserved, indicating that this endocrine activity is fully independent of mechanisms underlying the GH-releasing effect. These results do not support the hypothesis that ghrelin deficiency is a major cause of isolated GH deficiency but suggest that ghrelin might represent a reliable provocative test to evaluate the maximal GH secretory capacity provided that appropriate cut-off limits are assumed.
引用
收藏
页码:765 / 771
页数:7
相关论文
共 43 条
  • [1] Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone plus arginine as provocative tests for the diagnosis of GH deficiency in adults
    Aimaretti, G
    Corneli, G
    Razzore, P
    Bellone, S
    Baffoni, C
    Arvat, E
    Camanni, F
    Ghigo, E
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (05) : 1615 - 1618
  • [2] Comparisons among old and new provocative tests of GH secretion in 178 normal adults
    Aimaretti, G
    Baffoni, C
    DiVito, L
    Bellone, S
    Grottoli, S
    Maccario, M
    Arvat, E
    Camanni, F
    Ghigo, E
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 142 (04) : 347 - 352
  • [3] Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans
    Arvat, E
    Di Vito, L
    Broglio, F
    Papotti, M
    Muccioli, G
    Dieguez, C
    Casanueva, FF
    Deghenghi, R
    Camanni, F
    Ghigo, E
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2000, 23 (08) : 493 - 495
  • [4] Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: Comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone
    Arvat, E
    Maccario, M
    Di Vito, L
    Broglio, F
    Benso, A
    Gottero, C
    Papotti, M
    Muccioli, G
    Dieguez, C
    Casanueva, FF
    Deghenghi, R
    Camanni, F
    Ghigo, E
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) : 1169 - 1174
  • [5] MODULATION OF GROWTH HORMONE-RELEASING ACTIVITY OF HEXARELIN IN MAN
    ARVAT, E
    GIANOTTI, L
    DIVITO, L
    IMBIMBO, BP
    LENAERTS, V
    DEGHENGHI, R
    CAMANNI, F
    GHIGO, E
    [J]. NEUROENDOCRINOLOGY, 1995, 61 (01) : 51 - 56
  • [6] ARVAT E, 1999, GROWTH HORMONE SECRE, P139
  • [7] Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379
  • [8] Identification and characterization of a new growth hormone-releasing peptide receptor in the heart
    Bodart, V
    Bouchard, JF
    McNicoll, N
    Escher, E
    Carriere, P
    Ghigo, E
    Sejlitz, T
    Sirois, MG
    Lamontagne, D
    Ong, H
    [J]. CIRCULATION RESEARCH, 1999, 85 (09) : 796 - 802
  • [9] BORGES JLC, 1983, LANCET, V2, P119
  • [10] Unnatural growth hormone-releasing peptide begets natural ghrelin
    Bowers, CY
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) : 1464 - 1469